Company Filing History:
1 out of 3 
1 out of 1 
1 out of 2 Years Active: 2022
Title: Mark G Lesage: Innovator in Nicotine Addiction Treatment
Introduction
Mark G Lesage is an accomplished inventor based in Minneapolis, MN (US). He has made significant contributions to the field of nicotine addiction treatment through his innovative research and development of novel solutions.
Latest Patents
Mark G Lesage holds a patent for nicotine-binding antibodies. This patent describes novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, as well as for treating nicotine overdose or nicotine poisoning. He has 1 patent to his name.
Career Highlights
Throughout his career, Mark has worked with notable companies such as Antidote Therapeutics, Inc. and Blink Biomedical. His work has focused on developing effective treatments for nicotine-related issues, showcasing his dedication to improving public health.
Collaborations
Mark has collaborated with talented individuals in his field, including Matthew W Kalnik and Thomas Thisted. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Mark G Lesage is a notable inventor whose work in nicotine addiction treatment has the potential to make a significant impact on public health. His innovative approaches and collaborations highlight his commitment to addressing critical health challenges.